i havent seen strong evidence from myx reports or other generic companies thst the worst is over or that we are reaching an inflection point.
myxstill carries large debt and teva revenue is poor/ declining.
it should turn around but major industry changes duch as ghis may not happen as quickly asmany here seem to think.
i got burnt by myx on the way down so im cautious towards management and their rhetoric.
Add to My Watchlist
What is My Watchlist?
